Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study | MicrobiomeTrials
Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study
CompletedOBSERVATIONAL
Trial Details
Start: 2022-11-01Est. Completion: 2024-10-31
Enrollment target: 240 participants
Locations
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Università degli Studi di Padova - Unit Multivisceral Transplant Unit, Padova, Italy
Irccs Ismett, Palermo, Italy
ASST-Sette Laghi Università degli Studi dell'Insubria, Varese, Italy
Università degli Studi di Verona - Gastroenterologia, Verona, Italy
Hospital General Universitario Gregorio Maranon, Madrid, Spain
Other microbiome trials you might be interested in